SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals ($CRML) is trending as investors closely monitor developments in the rare earth element sector, particularly any movement on the Tanbreez project. Community discussions revolve around the potential impact of government policies and geopolitical factors on $CRML's prospects, alongside speculation regarding upcoming catalysts like the BFS report and potential partnerships.

What happens when you give Claude Code a blank webpage, and full control?

The Best Website Ever

BWE is trending negatively as the community expresses concerns about potential scams, rug pulls, and heavy shorting activity. Sentiment suggests expectations for continued downward movement, with many anticipating further drops and labeling the crypto as 'trash' and a 'scam company.' Talk of an impending bear market and potential dilution adds to the negative outlook.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending downwards amid concerns about a lowered revenue forecast due to data center delays, sparking discussions about the AI infrastructure sector's growth and profitability. Community members are debating whether this drop is an overreaction and a buying opportunity, or a sign of deeper issues like debt and market manipulation. Some are pointing fingers at a specific data center provider, while others are comparing $CRWV to competitors and discussing potential government intervention in AI infrastructure.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as investors digest its earnings report, a new $3 billion Meta contract, and news of a potential share dilution. Community members are debating the significance of the Meta deal and the company's growth prospects amid discussions about an AI bubble and comparing NBIS to competitors like CRWV. The stock's volatility and future potential in the AI infrastructure space remain key talking points.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the stock price hits a 16-month high, fueled by Citigroup increasing its stake and optimism around the upcoming R2 SUV. The community is buzzing about the potential for further gains and comparing Rivian's trajectory to Tesla's, while also debating the impact of the CEO's new performance-based compensation package. Some are seeing a breakout pattern and anticipating a move towards higher price targets.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

LFS is trending due to a massive intraday surge, with traders actively discussing the reasons behind the sudden spike, including potential news catalysts or a possible short squeeze. The stock's impressive move is drawing attention to potential multi-day runner status, while some traders are looking for similar plays or sympathy stocks. Community members are debating whether it's too late to enter, while others are pointing to a potential pump and dump scenario.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is trending as investor sentiment shifts following news of expansion into additional European markets and recent focus list addition by Morgan Stanley. The community is also discussing Xpeng's innovative advancements in AI-integrated robotics and its potential to disrupt the EV and autonomous driving sectors. Many see the current valuation as heavily discounted compared to competitors like Tesla, highlighting the potential for significant growth.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation of a potential partnership with United Health and buyout offers, fueled by recent activity in the weight loss drug sector. Community discussions highlight the potential of Viking's GLP/GIP drug, VK2735, and its competitive edge over existing treatments. Positive sentiment surrounds the stock's potential, with some suggesting it is undervalued, while others remain cautious, noting the company's history.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as the company's analyst day sparks discussions around its long-term growth strategy and potential to capture a significant share of the expanding AI data center market. Community members are focused on AMD's projections for substantial revenue growth, particularly in the AI sector, and debate whether the stock is undervalued compared to competitors. Bullish sentiment is fueled by confidence in AMD's leadership and potential to challenge Nvidia in key markets.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is trending following a positive revenue update, leading to discussions about the company's growth trajectory and future potential. Community members are weighing in on the impact of the company's recent acquisition and expressing anticipation for upcoming earnings and catalysts, while also speculating on potential short squeezes. Some concerns persist around potential dilution and the company's strategy, with calls for stronger communication from management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)

Microbot Medical (MBOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval

STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.

All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy

Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.

Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market

MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.

Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?

Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus

One of the greatest challenges retail investors face is figuring out which stock is undervalued and finding the right entry point to buy that stock. However, history shows that these are the points where investors falter most often.Stocktwits recently conducted a poll asking users on the platform which stock in the robotics sector has the most upside in 2025. Of the three names—Richtech Robotics Inc. (RR), Serve Robotics Inc. (SERV), and Microbot Medical Inc. (MBOT)—retail investors chose to side with RR, which has witnessed the most downside over the last year.<figure class="image"><img style="aspect-ratio:1320/766;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/RR_poll_and_results_abc2021e3e.png" alt="RR poll and results.png" width="1320" height="766"></figure>Richtech Robotics lost nearly 59% of its market capitalization during this period, compared to SERV's almost 28% loss and MBOT's 43% gain.Even from a year-to-date perspective, RR stock has gained just about 14%, SERV has risen over 27%, and MBOT has increased over 80%. This leaves more room for RR to pare its losses after last year’s disappointing performance.Interestingly, it appears retail investors are betting on the stock that seems to be undervalued due to its price movement. The question is whether a significant decline in stock price indicates an equally lucrative potential for a reversion to the mean or a persisting weakness in the fundamentals.Another notable metric appears to be the short interest on these stocks. According to KoyFin, RR has the lowest short interest among the three names of about 3.1% while MBOT has a short interest of about 3.4% and SERV has a short interest of about 5.7%. Although the numbers do not seem significant, the needle still points toward RR as the best choice.Investor perception, too, is a crucial deciding factor. While MBOT stock appears to be the least undervalued of the three stocks, SERV shares have drawn some negative reactions recently. The company announced $80 million worth of direct offering, drawing negative reactions from investors.This development also favors RR as the stock with the most upside this year.However, markets never cease to surprise, and with 2025 just two weeks old, investors will have plenty of time to assess how the evolving macro picture affected these companies' fundamentals.It will also be interesting to analyze whether the much-talked-about mean reversion worked for RR stock.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/gbtg-stock-falls-on-dojs-lawsuit/chGWtrMRZC">Global Business Travel Group Stock Falls On DOJ’s Lawsuit To Block Acquisition Of CWT Holdings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market data with uptrend vector | Illustration Source: Getty Images

Stocktwits Poll: Retail Investors Bet RR Stock Will Have Most Upside In 2025 Among Robotics Players

Richtech Robotics lost nearly 59% of its market capitalization in the period, compared to a nearly 28% loss posted by SERV and a 43% gain registered by MBOT during the period.

Equity

Richtech Robotics lost nearly 59% of its market capitalization in the period, compared to SERV's nearly 28% loss and MBOT's 43% gain.

Microbot Medical Gets Quality Certification for its System

Microbot Medical Inc. (NASDAQ: MBOT) recently announced the receipt of ISO 13485:2016 certification for its quality management system.
read more...

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this applicationBRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot...

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Microbot Medical Inc

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with CoreWeave ($CRWV) stock on the post-earnings decline?

MBOT
Microbot Medical Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MBOT News

MBOTMicrobot Medical Inc